GSK company profile

GSK · LSE · GBp

Compare GSK
1,869.00 GBpChange from previous close: −3.14%Absolute change: −60.50 GBp

Close · November 17, 2026

Company profile

GSK has 66,841 employees and is headquartered in London, United Kingdom.

Shingles, RSV and HPV vaccines, HIV medicines, and inhalers for asthma and COPD are the products most people associate with the group. Its work covers vaccines, specialty medicines and general medicines, and it also develops oral small-molecule therapies for oncology and inflammatory diseases. Customers are in the United Kingdom, the United States and other markets abroad, and its collaborations include an mRNA vaccine project with CureVac and a tuberculosis alliance with AN2 Therapeutics.

In the fiscal year ended December 2025, revenue was GBP 32.7 billion, up 4.1% from the previous year, and net profit reached GBP 5.7 billion. The United States generated 51.6% of revenue, international markets 25.3%, Europe 21.0% and Britain 2.1%. The company employed 66,841 people and is headquartered in London, where it was founded in 1715 and changed its name from GlaxoSmithKline to GSK plc in May 2022. Its shares also trade on the New York Stock Exchange.

Company facts

Industry
Drug Manufacturers - General
Headquarters
79 New Oxford Street, WC1A 1DG, London
Employees
66,841
Chief executive
Luke Miels
Founded
1715
Fiscal year
January - December
Listing
GSK · LSE
Indices
FTSE 100
Currency
GBp
ISIN
GB00BN7SWP63
Website
gsk.com

GSK and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
GSKGSKUnited Kingdom$102.04B66,84130.5%18.0
SanofiSANFrance$116.52B74,84622.3%25.5
BayerBAYNGermany$61.54B87,77516.5%—
Novo NordiskNOVO.BDenmark$184.87B68,79450.8%11.2
AstraZenecaAZNUnited Kingdom$287.12B96,10025.8%26.6
NovartisNOVNSwitzerland$305.16B75,26734.0%32.6

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare GSK with its competitors